HOPKINTON, Mass., March 15 /PRNewswire-FirstCall/ -- Caliper Life Sciences, Inc. today announced that Kevin Hrusovsky, president and chief executive officer, will deliver a keynote address at ScreenTech 2006, on Wednesday, March 22, in San Diego. The topic of the address is "Experimentation Technology Innovation Can Transform Drug Discovery."
Hrusovsky's presentation will examine how the integration of innovative in vitro, in vivo, and in silico technologies can provide drug discovery scientists with more clinically relevant information earlier in the drug discovery process.
"Our partner customers in the pharmaceutical industry are asking us to create tools that will help them better predict safety and efficacy of new drug candidates all throughout the discovery pipeline," commented Hrusovsky. "Our response is to pursue next-generation platforms that produce more clinically relevant data by incorporating pharmacologically validated models that bridge small animal, in vitro and in silico approaches."
In a related presentation, Ralph Lambalot, Ph.D., director, Protein Biology, Pfizer Global R&D, will discuss the strategies Pfizer employed to build an integrated kinase selectivity screening platform, including the use of Caliper's microfluidic-based LabChip 3000 system, for the biological screening of enzymatic and cell-based assays.
For more information please visit the Caliper Life Sciences booth #200 at the conference.
Screen Tech 2006, "Screening to Analysis," is an annual event designed to bring scientists, assay developers, screeners and investigators together to form a community focused on advancing drug targets.
About Caliper Life Sciences
Caliper Life Sciences is a leading provider of drug discovery and life sciences research solutions for the pharmaceutical and biotechnology industries. Caliper's mission is to transform drug discovery and diagnostics by offering the industry's most comprehensive array of products of services for clinically relevant experimentation. Based in Hopkinton, Massachusetts, Caliper services approximately 80 percent of the world's leading pharmaceutical companies through representation in thirty countries. More information about Caliper and its products and services can be found on the web at www.caliperLS.com.
NOTE: LabChip is a registered trademark of Caliper Life Sciences, Inc.
Caliper Life Sciences, Inc.CONTACT: Michele Boudreau of Caliper Life Sciences, +1-650-279-2088; orAndrea tenBroek of Schwartz Communications, +1-781-684-0770, orcaliper@schwartz-pr.com, for Caliper Life Sciences
Web site: http://www.caliperLS.com/
